VKTX - Viking Therapeutics Inc logo

VKTX

Viking Therapeutics Inc

Rev โ€”top 1%10Y
Hold

Viking Therapeutics develops therapies for metabolic and endocrine disorders, focusing on drugs like VK2809 for non-alcoholic steatohepatitis and VK5211 for hip fracture recovery. Its pipeline includes several candidates in various clinical trial phases.

โš•๏ธ Healthcare NASDAQ Listed 2015 $ USD
$1,000 invested 10 years ago โ†’$25,969today

Score Overview

1 Year
Scoreโ€”
Net Growth-48.70%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score0.1
Net Growth-7x
Net TrendNever
Net Income Consistencyโ€”
Rev Growth-100.00%
Rev TrendNever
Revenue Consistencyโ€”
10 Years
Scoreโ€”
Net Growth-34x
Net TrendNever
Net Income Consistency
Rev Growthโ€”
Rev Trend10%
Revenue Consistency
All Time
Scoreโ€”
Net Growth-20x
Net Trend9%
Net Income Consistency
Rev Growthโ€”
Rev Trend9%
Revenue Consistency

See the full market ranking โ†’

Viking Therapeutics Inc fundamental performance

Between 2020 and 2025, revenue declined from $ 10.73K to $ 0.00 and net income went from -$ 39M to -$ 359M. Revenue increased in 0 of those 5 years; net income in 0.

Viking Therapeutics Inc currently holds a 5-year HDB Score of 0.1 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 34.02โ€”
1 Year2025-08-12
$ 39.86-14.65%
5 Years2021-08-12
$ 6.01466.06%
10 Years2016-08-12
$ 1.3125x
All Time2015-04-29
$ 8.96279.69%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 0.00-$ 534M$ 125M
2025$ 0.00-$ 359M$ 705M
2024$ 0.00-$ 109M$ 902M
2023$ 0.00-$ 85M$ 362M
2022$ 0.00-$ 68M$ 155M
2021$ 10.7K-$ 54M$ 202M
2020$ 10.73K-$ 39M$ 248M
2019$ 0.00-$ 25M$ 275M
2018$ 0.00-$ 22M$ 301M
2017$ 0.00-$ 20M$ 20M
2016$ 0.00-$ 14M$ 13M
IPO2015$ 0.00-$ 23M$ 14M

Explore beyond VKTX

You're looking at Viking Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies